Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers ...

A new study has concluded that a blood test can identify whether the body’s organs are aging faster than expected ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Blood Test May Rule out Future Dementia Risk Apr. 2, 2025 — Researchers have demonstrated how specific biomarkers in the blood can predict the development of dementia up to ten years before ...